Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC .
Filed returns
9
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2022 | Janssen Sciences Ireland UC | Health | J&J hosted an exhibit at the ALDE Congress in Dublin, which showcased health and life sciences innovation from across Europe, including cutting edge treatments for cancer, robotic surgery and 3D printing,… (Public policy or programme) | 11 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Health | Sharing information on challenges in medicines reimbursement process in Ireland (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion on issues affecting biopharmaceutical and manufacturing technology industries in Ireland including specialised skills and talent, digital strategy, energy policy, healthcare and medicines policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Event at the DePuy Synthes site in Co. Cork to mark the formal launch of Johnson & Johnson entering into an eight-year corporate power purchase agreement in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Health | Sharing copy of a new report on Cell and Gene therapies (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion with Minister on investment in R&D, STEM talent and skills to enable Ireland to achieve its ambition of becoming an innovation leader. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | Janssen Sciences Ireland UC | Health | Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2018 | Janssen Sciences Ireland UC | Economic Development and Industry | Impact of Brexit on the Life Sciences Sector (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2018 | Janssen Sciences Ireland UC | Economic Development and Industry | Impact of Brexit (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 5 | 55.6% | |
| Economic Development and Industry | 4 | 44.4% |